New web tool aims to ease tough surgery decisions for young breast cancer patients

NCT ID NCT06275126

Recruiting now Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether a web-based tool called CONSYDER can help young women (ages 18-44) newly diagnosed with early-stage breast cancer make more informed decisions about their surgery. Participants will use the tool and complete surveys before and after their surgical consultation. The goal is to reduce confusion and improve communication with surgeons, not to test a new drug or treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CONSYDER decision aid (web-based tool)
What this could lead to: If successful, this tool could help young breast cancer patients feel more confident and informed when choosing their surgery.
What could go wrong: This is an observational study measuring decision quality, not testing a treatment. The tool may not significantly improve outcomes or work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma in situ breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER STAGE I BREAST CANCER STAGE II BREAST CANCER STAGE III BREAST CANCER, STAGE 0

Contacts and locations

Locations

Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
Duke Cancer Institute
RECRUITING

Durham, North Carolina, 27710, United States
Weill Cornell Medicine
RECRUITING

New York, New York, 10065, United States
Yale Cancer Center
RECRUITING

New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.